Dr. Erika Hamilton, Associate Director of the Breast Cancer and Gynecologic Cancer Research Program at the Sarah Cannon Research Institute – the research arm of our global cancer enterprise, Sarah Cannon – was featured on Fox News in August to discuss a study released on DCIS, early stage breast cancer. DCIS (Ductal Carcinoma In Situ), commonly referred to as “stage zero breast cancer”, is an abnormal collection of cancer cells inside the milk ducts of the breasts. According to the American Cancer Society, approximately 60,000 women are diagnosed with DCIS each year. That’s one out of five new breast cancer cases annually.
How should DCIS be treated? Is surgery necessary or effective? Watch Dr. Hamilton’s interview to learn more about DCIS and the questions surrounding treatment options for this particular condition.
Sarah Cannon provides state-of-the-art cancer care and access to clinical trials close to home for hundreds of thousands of patients, a number unmatched by any single cancer center.